Related Experiment Video
Updated: May 27, 2026

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
Published on: August 12, 2016
Control-relevant models for glucose control using a priori patient characteristics
Klaske van Heusden1, Eyal Dassau, Howard C Zisser
1Department of Chemical Engineering, University of California, Santa Barbara, Santa Barbara, CA 93106 USA. KvHeusden@gmail.com
Developing accurate artificial pancreas models for type 1 diabetes mellitus (T1DM) is challenging. This study presents personalized, control-relevant models that successfully avoid hypoglycemia in silico, simplifying artificial pancreas control for physicians.
Area of Science:
- Biomedical Engineering
- Control Systems
- Endocrinology
Background:
- Accurate glucose control in type 1 diabetes mellitus (T1DM) is hindered by patient-model mismatch in artificial pancreas systems.
- Existing model-based control algorithms struggle to prevent both postprandial hypoglycemia and hyperglycemia.
Purpose of the Study:
- To develop control-relevant mathematical models for T1DM that prioritize safety by minimizing hypoglycemia risk.
- To personalize these models using patient characteristics to account for inter-subject variability.
- To implement and evaluate these models within a zone model predictive control (ZMPC) algorithm.
Main Methods:
- Development of T1DM models focused on control relevance rather than prediction error minimization.
- Conservative parameter selection to reduce hypoglycemia likelihood.
- Personalization of models using a priori patient data.
- Implementation in a ZMPC algorithm and in silico robustness evaluation.
Main Results:
- Hypoglycemia was completely avoided in silico, even with significant meal disturbances.
- The developed control-relevant models demonstrated robustness in simulated environments.
- The proposed control approach proved effective in preventing dangerous glucose level drops.
Conclusions:
- Personalized, control-relevant models can enhance the safety and reliability of artificial pancreas systems for T1DM.
- The developed ZMPC algorithm offers a robust solution for glucose control, minimizing hypoglycemia risks.
- This approach simplifies controller setup for physicians, requiring no specialized control expertise.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Diabetes Mellitus: Type 2 and Gestational
Oral Hypoglycemic Agents: Biguanides and Glitazones
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Hypoglycemia and Glucagon
